These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9662340)

  • 1. BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins.
    Fan S; Wang JA; Yuan RQ; Ma YX; Meng Q; Erdos MR; Brody LC; Goldberg ID; Rosen EM
    Oncogene; 1998 Jun; 16(23):3069-82. PubMed ID: 9662340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
    Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
    Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1.
    Fan S; Yuan R; Ma YX; Meng Q; Goldberg ID; Rosen EM
    Oncogene; 2001 Dec; 20(57):8215-35. PubMed ID: 11781837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRCA1 and prostate cancer.
    Rosen EM; Fan S; Goldberg ID
    Cancer Invest; 2001; 19(4):396-412. PubMed ID: 11405179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53.
    Ramirez PT; Gershenson DM; Tortolero-Luna G; Ramondetta LM; Fightmaster D; Wharton JT; Wolf JK
    Gynecol Oncol; 2001 Dec; 83(3):543-8. PubMed ID: 11733969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors.
    Sourvinos G; Spandidos DA
    Biochem Biophys Res Commun; 1998 Apr; 245(1):75-80. PubMed ID: 9535786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Ets transcription factor activity in prostate tumor cells inhibits anchorage-independent growth, survival, and invasiveness.
    Foos G; Hauser CA
    Oncogene; 2000 Nov; 19(48):5507-16. PubMed ID: 11114728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutive activation of JAK-STAT3 signaling by BRCA1 in human prostate cancer cells.
    Gao B; Shen X; Kunos G; Meng Q; Goldberg ID; Rosen EM; Fan S
    FEBS Lett; 2001 Jan; 488(3):179-84. PubMed ID: 11163768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1.
    Zacharatos PV; Gorgoulis VG; Kotsinas A; Manolis EN; Liloglou T; Rassidakis AN; Kanavaros P; Field JD; Halazonetis T; Kittas C
    Anticancer Res; 1999; 19(1A):579-87. PubMed ID: 10226602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression activity of pro-apoptotic gene products in cancer cells, a potential application for cancer gene therapy.
    Lin J; Page C; Jin X; Sethi AO; Patel R; Nunez G
    Anticancer Res; 2001; 21(2A):831-9. PubMed ID: 11396172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinate alterations in the expression of BRCA1, BRCA2, p300, and Rad51 in response to genotoxic and other stresses in human prostate cancer cells.
    Yuan R; Fan S; Wang JA; Meng Q; Ma Y; Schreiber D; Goldberg ID; Rosen EM
    Prostate; 1999 Jun; 40(1):37-49. PubMed ID: 10344722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
    Piovesan B; Pennell N; Berinstein NL
    Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1.
    Somasundaram K; Zhang H; Zeng YX; Houvras Y; Peng Y; Zhang H; Wu GS; Licht JD; Weber BL; El-Deiry WS
    Nature; 1997 Sep; 389(6647):187-90. PubMed ID: 9296497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.
    Hakem R; de la Pompa JL; Sirard C; Mo R; Woo M; Hakem A; Wakeham A; Potter J; Reitmair A; Billia F; Firpo E; Hui CC; Roberts J; Rossant J; Mak TW
    Cell; 1996 Jun; 85(7):1009-23. PubMed ID: 8674108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
    Tang DG; Li L; Chopra DP; Porter AT
    Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of BRCA1 in heat shock response.
    Xian Ma Y; Fan S; Xiong J; Yuan RQ; Meng Q; Gao M; Goldberg ID; Fuqua SA; Pestell RG; Rosen EM
    Oncogene; 2003 Jan; 22(1):10-27. PubMed ID: 12527903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [WAF1/CIP1/p21 gene in wild type p53 and mutant p53 human breast cancer cell lines in relation to its cytobiological features].
    Jiang M; Shao Z; Wu J
    Zhonghua Zhong Liu Za Zhi; 1998 May; 20(3):181-4. PubMed ID: 10921001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
    Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
    Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.